1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. China National Accord Medicines Corporation Ltd.
  6. Summary
    000028   CNE0000009N6

CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.

(000028)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-07
28.87 CNY   +0.52%
06/13China National Accord Medicines Corporation Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 17, 2022
CI
04/27China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/25China National Accord Medicines Corporation Ltd. Approves Final Cash Dividend for the Year 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
08/02/2022 08/03/2022 08/04/2022 08/05/2022 08/08/2022 Date
27.7 28.22 28.27 28.72 28.87 Last
2145677 2442588 969444 1195678 876149 Volume
-3.89% +1.88% +0.18% +1.59% +0.52% Change
Estimated financial data (e)
Sales 2022 74 583 M 11 047 M 11 047 M
Net income 2022 1 372 M 203 M 203 M
Net cash position 2022 1 856 M 275 M 275 M
P/E ratio 2022 9,02x
Yield 2022 3,14%
Sales 2023 81 922 M 12 134 M 12 134 M
Net income 2023 1 585 M 235 M 235 M
Net cash position 2023 2 059 M 305 M 305 M
P/E ratio 2023 7,80x
Yield 2023 3,53%
Capitalization 11 596 M 1 718 M 1 718 M
EV / Sales 2022 0,13x
EV / Sales 2023 0,12x
Nbr of Employees 39 386
Free-Float 42,7%
More Financials
Company
China National Accord Medicines Corporation Ltd. is a China-based company principally engaged in the pharmaceutical wholesaling, retailing and manufacturing businesses. The Company's main products include antibiotic preparations, power injections, antibiotic Active Pharmaceutical Ingredients (APIs), respiratory system drugs and cardiovascular and cerebrovascular system drugs, among others. The Company is also... 
Sector
Pharmaceuticals
Calendar
08/27Earnings Release
More about the company
Ratings of China National Accord Medicines Corporation Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
06/13China National Accord Medicines Corporation Ltd. Announces 2021 Final Profit Distributi..
CI
04/27China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First..
CI
04/25China National Accord Medicines Corporation Ltd. Approves Final Cash Dividend for the Y..
CI
04/04Nomura Adjusts China National Accord Medicines' Price Target to 49.1 Yuan From 54.5 Yua..
MT
03/30China National Accord Medicines Corporation Ltd. Proposes Final Cash Dividend for the Y..
CI
03/16China National Accord Medicines' Profit Slips 5% in 2021 on Impairment Provision
MT
03/15China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full ..
CI
2021CHINA NATIONAL ACCORD MEDICINES' : Q3 Profit Falls 6.1%
MT
2021China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Nine ..
CI
2021China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Half ..
CI
2021China National Accord Medicines Corporation Ltd. Announces Board Elections
CI
2021China National Accord Medicines Corporation Ltd. Announces Final Dividend on A Shares f..
CI
2021China National Accord Medicines Corporation Ltd. Approves 2020 Profit Distribution Plan..
CI
2021China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First..
CI
2021China National Accord Medicines Corporation Ltd. Proposes Final Cash Dividend for the Y..
CI
More news
News in other languages on CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
06/13China National Accord Medicines Corporation Ltd. annonce la mise en oeuvre du plan fina..
04/27China National Accord Medicines Corporation Ltd. annonce ses résultats pour le premier ..
04/25China National Accord Medicines Corporation Ltd. approuve le dividende final en espèces..
03/30China National Accord Medicines Corporation Ltd. Propose un dividende final en espèces ..
03/16Le bénéfice de China National Accord Medicines a chuté de 5 % en 2021 en raison d'une p..
More news
Analyst Recommendations on CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
More recommendations
Chart CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
Duration : Period :
China National Accord Medicines Corporation Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 28,87 CNY
Average target price 35,50 CNY
Spread / Average Target 23,0%
EPS Revisions
Managers and Directors
Zhao Xiong Lin General Manager
Ping Xiao Wei Chief Financial & Accounting Officer
Yong Liu Chairman
Zhi Yi He Independent Director
Chu Xiong Xiong Independent Director